COLL· Collegium Pharmaceutical Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 0 | $0 |
Quarterly ownership history
Last 6 quarters
COLL Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$1.2B
Enterprise value$1.7B
EV / EBITDA (TTM)4.05
P/E ratio (TTM)18.35
Forward P/E5.31
P/S ratio1.54
P/B ratio3.92
PEG ratio—
Cash Flow
Operating cash flow (TTM)$331M
Free cash flow (TTM)$335M
Total cash$422M
Total debt$930M
Debt / equity297.57
Current ratio1.71
Income Statement
Total revenue (TTM)$796M
Revenue per share (TTM)25.06
Gross profit (TTM)$714M
EBITDA (TTM)$429M
Net income (TTM)$75M
EPS diluted (TTM)2.06
Shares outstanding32,433,779
Float shares32,061,764
Profitability
Gross margin89.61%
Operating margin15.96%
EBITDA margin53.81%
Net margin9.41%
Efficiency
Return on assets (TTM)7.73%
Return on equity (TTM)27.41%
Price History
Current price$37.80
52 Week high$50.79
52 Week low$28.34
50 day average$35.03
200 day average$39.52
Average volume (10 day)541,530
1-year beta—
1-year price target$54.33
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:36 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com